[C001]
First synthesis of (8-2H3)-(all-rac)-d-tocopherol
Francesco Mazzini*, [a] Emanuele Alpi,[a] Piero Salvadori, [a] Thomas Netscher[b]
[a] Dipartimento di Chimica e Chimica Industriale, Università di Pisa Via Risorgimento 35, 56126 Pisa, Italy
E-mail: lcap@server1.dcci.unipi.it
[b] Research and Development, Roche Vitamins Ltd CH-4070 Basel, Switzerland E-mail: thomas.netscher@roche.com
4 Choice of deuteration position
4Synthesis of alfa and beta tocopherol
4Synthetic approach to d-tocopherol: % route A L route B
Vitamin
E (tocopherols and tocotrienols) is protective against many diseases
(cancer, cardiovascular diseases[1],
oxidation of low-density lipoproteins[2]).
Tocopherols are present in oil seeds, leaves and other green parts of higher
plants. Since vitamin E is only synthesized by plants, it is a very important
dietary nutrient for humans and animals[3].
For accurate simultaneous
quantitative determination of tocopherols in food matrices by LC-MS trideuterated tocopherols were
needed. Procedures for trideuterated a- and b-tocopherol have been
recently optimized, whilst no method is reported as regards d-tocopherol.
Different synthetic
approach are discussed, as well as procedure for the synthesis of (8-2H3)-(all-rac)-d-tocopherol, (5-2H3)-(all-rac)-b-tocopherol and (5-2H3)-(all-rac)-a-tocopherol.
Choice of the deuteration position
In order to avoid cross
talk phenomena and to follow the most abundant ion in quantitative analyses by
tandem mass spectrometry, the position of labelling was chosen on the base of
tocopherol fragmentation pattern. The fragment resulting from loss of the
aliphatic chain and breaking of the pyran ring is the most abundant in this
kind of analyses[4]. Hence
we considered to introduce convenient labeling into the aromatic methyl group
for our purposes.
characteristic fragment
Synthesis of alfa and beta tocopherol
Several synthetic
procedures for the preparation of poly-deuterated tocopherols are known. Mainly
the deuterium is introduced by use of labeled formaldehyde and reducing
reagents[5].
For the synthesis of trideuterated (all-rac)-a- and b-tocopherol we used a recently
optimized procedure[6], by
which the corresponding (2H2)-morpholinomethyl
tocopherol is prepared by a Mannich reaction and then reduced with NaCNBD3
(5-2H3)-(all-rac)-b-tocopherol (5-2H3)-(all-rac)-a-tocopherol.
i) morpholine (4 equiv.), (CD2O)n (4 equiv.), 80
°C, 2 h, 94%; ii) NaCNBD3, isobutanol,
reflux, 91%; iii) morpholine
(1.3 equiv.), (CD2O)n, (1.3 equiv.), 80 °C, 2 h, 78%; iv) NaCNBD3, isobutanol, reflux, 90%
Synthetic
approach to d-tocopherol
The synthesis of (all-rac)-d-tocopherol containing labeling in
the aromatic methyl group required a totally different approach. We envisaged
two routes for the preparation of a suitable trideuterated aromatic building
block to be used in subsequent acid-catalyzed condensation reaction with isophytol.
Protection of the phenolic group in position 5 is generally required to avoid
the formation of 5- and 7-monomethyl regioisomers and possible
double-alkylation products in the condensation step.
Successful examples for
the transformation of the least hindered phenolic group into a benzyl ether (O-benzyl group: stable under the
condensation reaction and mild removal conditions) in 2,5-dihydroxybenzoic acid
or esters are reported in literature[7].
On a theorical base, the
ester 1 moiety can be reduced
to a methyl group through a multi-step reduction sequence with the benzylic
alcohol 2 as an intermediate.
Unfortunately, we were unable to isolate the corresponding MsO-, TsO-, Br-, or
Cl- for the last step because they proved to be very unstable. Neither
performing the whole sequence one pot was successful. These results prompted us
follow the route a.
Route
a : Synthesis of (8-2H3)-(all-rac)-d-tocopherol
To prepare (a,a,a-2H3)-2,5-dihydroxytoluene we envisaged and followed two possible ways.
Very good conversion was
observed in the metalation of the MOM and methyl hydroquinone derivatives (up
to 92%; BuLi 1.1eq., CH3I 5 eq., rt), but we
were not able to separate the products from about 7-10% of the starting
reagents.
Conversely synthesis of pure 3 was performed starting from commercially available 2,5-dihydroxybenzoic acid with 50% yield over six steps[8].
i) MeOH, H2SO4, 96%; ii) 1. NaH/THF 2.
CH3I, 92%; iii) LiAlD4/THF, 92%; iv) PBr3/CH2Cl2, sublimation, 82%; v)
LiAlD4/THF, 91%; vi) BBr3/CH2Cl2, 82%.
3 was then converted to a
mixture of monoprotected benzoates 4 and 5 (ca. 65:35). 4 was isolated by
fractionating crystallization and careful flash cromatography (45% on a 800-mg
scale). Though this result is not exalting, this procedure is the best up to
now for the synthesis of 5-benzoyloxy-2-hydroxytoluene.
The ZnCl2 catalyzed condensation
of 4 with isophytol gave
pure (8-2H3)-(all-rac)-d-tocopherol 6 after saponification in
60% yield with a 98.5% deuteration of CD3.
i) PhCOCl/Py; ii) flash chromatography separation, recrystallization, 45% ; iii) ZnCl2 (1.5 equiv.), iBuOAc, aq. HCl (cat.) , isophytol, iv) KOH/MeOH, rt, iii+iv 60%.
[1] K. F. Gey, P. Puska, Ann. N. Y. Acad. Sci. 1989, 570, 268-282.
[2] A. Kamal-Eldin, L. -Ċ. Appelqvist, Lipids 1996, 31, 671-701.
[3] G. Pongcraz, H. Weiser, D. Matzinger,
Fat Sci. Technol. 1995, 97, 90-104.
[4] S. E. Scheppele, R. K. Mitchum, Ch. J. Rudolph Jr., K. F. Kinneberg, G.
V. Odell, Lipids 1972, 7, 297-304.
[5] L. Hughes, M. Slaby, G. W. Burton, K. U. Ingold, J. Labelled Compd.
Radiopharm. 1990, 28, 1049-1057.
[6] Fifth Electronic Conference on
Synthetic Organic Chemistry, 1-30 Sept. 2001, http://www.mdpi.org/ecsoc-5.htm,
Molecular Diversity Preservation International, Basel, Switzerland,
contribution c0007.
[7] U. Schmidt, H. Bokens, A. Lieberknecht, H. Griesser, Tetrahedron Lett.
1981, 22, 4949-4952.
[8] S. J. Zweig, N. Jr. Castagnoli, J. Med. Chem. 1977, 20, 414-421.